Bertram Bengsch
Principal Investigator
Department of Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases
Medical Center University of Freiburg
Hugstetter Straße 55
79106 Freiburg
- +49 761 270-32870
- bertram.bengsch@uniklinik-freiburg.de
- Homepage
Current position
Academic training
| 2002 - 2008 | Study of Medicine in Freiburg with electives in London, GB, and Philadelphia, USA |
Advanced academic qualifications
| 2013 | PhD Dissertation (Faculty of Biology & SGBM), University of Freiburg |
| 2008 | MD Dissertation, Faculty of Medicine, University of Freiburg |
Postgraduate Positions
| 2023 | Board certification, Gastroenterology |
| 2020 | Heisenberg Professor, Faculty of Medicine, Albert Ludwigs-Universität Freiburg & Section Head Translational Hepatogastroenterology, Internal Medicine II, University Medical Center Freiburg |
| 2020 | Attending physician, Clinic for Internal Medicine II, University Medical Center Freiburg |
| 2018 | Board certification, Internal Medicine Since 10/2017 Group leader, Clinic for Internal Medicine II, University Medical Center Freiburg |
| 2014–2017 | Postdoctorate (DFG Stipend) and Research Fellow, nstitute for Immunology & Parker Institute for Cancer Immunotherapy (Prof. E.J. Wherry), Perelman School of Medicine,University of Pennsylvania, Philadelphia, USA |
| 2013 | Visiting Scientist, Cardiff University, Division of Infection and Immunity (Prof. Price) |
| 2009–2014 | Fellow and Clinician Scientist, Department Internal Medicine II, University Medical Center Freiburg |
Miscellaneous (Honors, Awards)
| 2020, 2023, 2024 | Clarivate Web of Sciences Highly cited researcher |
| 2014, 2015 | University of Pennsylvania, IGG retreat, best poster prize |
| 2011, 2013 | EASL young investigator award |
| 2008 | Ismar-Boas Prize – Prize (DGVS) for excellent medical thesis |
| 2006–2007 | Prize for distinguished dedication to academic Teaching, Medical Faculty Freiburg, Project „Cicil“ |
| 2006 | Media Prize 2006, University Freiburg |
Publications listed in PubMed®
Publications (based on CRC1479 funding)
Braun LM, Giesler S, Andrieux G, Riemer R, Talvard-Balland N, Duquesne S, Rückert T, Unger S, Kreutmair S, Zwick M, Follo M, Hartmann A, Osswald N, Melchinger W, Chapman S, Hutchinson JA, Haferkamp S, Torster L, Kött J, Gebhardt C, Hellwig D, Karantzelis N, Wallrabenstein T, Lowinus T, Yücel M, Brehm N, Rawluk J, Pfeifer D, Bronsert P, Rogg M, Mattern S, Heikenwälder M, Fusco S, Malek NP, Singer S, Schmitt-Graeff A, Ceteci F, Greten FR, Blazar BR, Boerries M, Köhler N, Duyster J, Ihorst G, Lassmann S, Keye P, Minguet S, Schadendorf D, Ugurel S, Rafei-Shamsabadi D, Thimme R, Hasselblatt P, Bengsch B, Schell C, Pearce EL, Meiss F, Becher B, Funke-Lorenz C, Placke JM, Apostolova P, Zeiser R. Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunity. Cancer Cell. 2025 Feb 10;43(2):269-291.e19. doi: 10.1016/j.ccell.2025.01.004.
Velasco Cárdenas RM, Brandl SM, Meléndez AV, Schlaak AE, Buschky A, Peters T, Beier F, Serrels B, Taromi S, Raute K, Hauri S, Gstaiger M, Lassmann S, Huppa JB, Boerries M, Andrieux G, Bengsch B, Schamel WW, Minguet S. Harnessing CD3 diversity to optimize CAR T cells. Nat Immunol. 2023 Nov 6. doi: 10.1038/s41590-023-01658-z. Epub ahead of print.
Edwards-Hicks J, Apostolova P, Buescher JM, Maib H, Stanczak MA, Corrado M, Klein Geltink RI, Maccari ME, Villa M, Carrizo GE, Sanin DE, Baixauli F, Kelly B, Curtis JD, Haessler F, Patterson A, Field CS, Caputa G, Kyle RL, Soballa M, Cha M, Paul H, Martin J, Grzes KM, Flachsmann L, Mitterer M, Zhao L, Winkler F, Rafei-Shamsabadi DA, Meiss F, Bengsch B, Zeiser R, Puleston DJ, O’Sullivan D, Pearce EJ, Pearce EL. Phosphoinositide acyl chain saturation drives CD8+ effector T cell signaling and function. Nat Immunol. 2023 Mar;24(3):516-530. doi: 10.1038/s41590-023-01419-y. Epub 2023 Feb 2.
Barsch M, Salié H, Schlaak AE, Zhang Z, Hess M, Mayer LS, Tauber C, Otto-Mora P, Ohtani T, Nilsson T, Wischer L, Winkler F, Manne S, Rech A, Schmitt-Graeff A, Bronsert P, Hofmann M, Neumann-Haefelin C, Boettler T, Fichtner-Feigl S, van Boemmel F, Berg T, Rimassa L, Di Tommaso L, Saeed A, D’Alessio A, Pinato DJ, Bettinger D, Binder H, John Wherry E, Schultheiss M, Thimme R, Bengsch B. T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma. J Hepatol. 2022 Aug;77(2):397-409. doi: 10.1016/j.jhep.2022.02.032. Epub 2022 Apr 1.
Contact
